Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

Clair, E. William St.; Heijde, Désirée van der; Smolen, Josef S; Maini, Ravinder N.; Bathon, Joan M.; Emery, Paul; Keystone, Edward; Schiff, Michael; Kalden, Joachim R.; Wang, Ben; DeWoody, Kimberly L.; Weiss, Roberta; Baker, Daniel L.; Group, Active‐Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study

doi:10.1002/art.20568

articleArthritis & RheumatismNov 1, 2004Closed access

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

EWE. William St. Clair DVDésirée van der Heijde JSJosef S Smolen RNRavinder N. Maini JMJoan M. Bathon

Duke Medical Center · Maastricht University Medical Centre · +7 more institutions

PubMed

Indexed incrossrefpubmed

Abstract

OBJECTIVE: To compare the benefits of initiating treatment with methotrexate (MTX) and infliximab (anti-tumor necrosis factor alpha [anti-TNFalpha] monoclonal antibody) with those of MTX treatment alone in patients with rheumatoid arthritis (RA) of

Citation impact

1,165

total citations

FWCI: 52.08
Percentile: 100%
References: 42

Citations per year

Authors

14

Topics & keywords

Topics

Keywords

Infliximab
Medicine
Rheumatoid arthritis
Methotrexate
Placebo
Internal medicine
Gastroenterology
Arthritis

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.